This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top 5 Stocks With Solid Earnings Beat Potential
by Sanghamitra Saha
Inside the top-ranked stocks that can beat earnings estimates in their next releases.
Auto Sales Plunge in Q2: ETFs & Stocks in Focus
by Sweta Killa
Major automakers reported a more than 30% drop in U.S. auto sales in the second quarter, the biggest plunge since the Great Recession.
5 Auto Stocks to Buy & 5 to Sell as Markets Move Up
by Sejuti Banerjea
Here is a common-sense principle to help you decide which stocks to buy and which to sell.
5 Top-Ranked Stocks Likely to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
The Market Timing Secrets No One Talks About - June 19, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Why the Sell-Off in These 5 Stocks is a Buying Opportunity
by Nilanjan Choudhury
We have zeroed in on five stocks that have witnessed a slump this past week but have a favorable Zacks Rank #1 (Strong Buy) or 2 (Buy).
Is Navistar (NAV) Positioned Well to Rebound From The Slump?
by Zacks Equity Research
Navistar anticipates 2021 to be a better year, but does not expect sales and earnings to return to 2018 and 2019 levels by then.
Worried About a Weak Dollar? Here's How to Trade & Win
by Sanghamitra Saha
The ultra-easy Fed policy and widening U.S. deficit are likely to keep the greenback subdued in this coming days.
High-Beta ETFs & Stocks to Tap the Soaring Stock Market
by Sweta Killa
While every corner of the market is enjoying this ascent, high-beta ETFs and stocks seem a perfect bet at present.
Toyota (TM) Partners With Chinese Firms for Fuel-Cell Systems
by Zacks Equity Research
Toyota (TM) aims to supply fuel-cell systems for commercial vehicles in China as well as strengthen its ties with Chinese companies.
Adient (ADNT) Up 29.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Keys to Successfully Timing the Markets - May 27, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Tesla (TSLA) Cuts Prices by 6% in North America, 4% in China
by Zacks Equity Research
Tesla's Model S and X are now priced at $74,990 and $79,990, respectively in North America.
Adient's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Adient.
Volkswagen Dieselgate Update: Here's What You Should Know
by Zacks Equity Research
As Volkswagen (VWAGY) loses the landmark Dieselgate case in its home country, the court rules that the claimants are entitled to return their vehicles for partial reimbursement of the purchase price.
Cost-Cutting Actions Aid Magna (MGA) Amid Coronavirus Scare
by Zacks Equity Research
Magna (MGA) is well poised to benefit from expanding its business through joint ventures and hub openings amid the coronavirus pandemic
Here's Why You Should Dump Autoliv From Your Portfolio Now
by Zacks Equity Research
For 2020, Autoliv (ALV) expects light-vehicle markets to witness a slump due to softening consumer confidence, trade tariffs and COVID-19 impacts, which in turn are likely to weigh on earnings.
Allison (ALSN) Tanks 27% Year to Date: Any Silver Lining?
by Zacks Equity Research
While coronavirus woes and elevated leverage are hurting the prospects of Allison Transmission (ALSN), defense end market strength and strategic buyouts provide a ray of hope.
Adient (ADNT) Tops Q1 Earnings & Sales Estimates, Scraps View
by Zacks Equity Research
Adient (ADNT) scraps 2020 guidance as management expects the coronavirus pandemic and related setbacks to strain its operations in the days to come.
Sell These Toxic Stocks to Avoid Portfolio Bleeding
by Zacks Equity Research
Figuring out toxic stocks and abandoning them at the right time is the key to shield your portfolio from big losses.
Adient (ADNT) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 93.75% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Market Timing Secrets No One Talks About - April 29, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Adient (ADNT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Adient (ADNT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
General Motors & Honda Collaborate for Development of Two EVs
by Zacks Equity Research
General Motors (GM) & Honda (HMC) to jointly develop two new electric vehicles for the latter, featuring the proprietary Ultium battery technology of the former.